OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 1
Open Access | Times Cited: 88
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 1
Open Access | Times Cited: 88
Showing 1-25 of 88 citing articles:
Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 8, pp. 1182-1200
Closed Access | Times Cited: 31
Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 8, pp. 1182-1200
Closed Access | Times Cited: 31
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 8, pp. 1051-1069
Closed Access | Times Cited: 16
Sindhu R. Johnson, Elana J. Bernstein, Marcy B. Bolster, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 8, pp. 1051-1069
Closed Access | Times Cited: 16
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Richard Furie, Brad H. Rovin, Jay Garg, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 3
Richard Furie, Brad H. Rovin, Jay Garg, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 3
COVID-19 and the peripheral nervous system
Benjamin Béland, Sarah Jacob, Gerald Pfeffer, et al.
Elsevier eBooks (2025), pp. 481-501
Closed Access | Times Cited: 1
Benjamin Béland, Sarah Jacob, Gerald Pfeffer, et al.
Elsevier eBooks (2025), pp. 481-501
Closed Access | Times Cited: 1
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus
Kavita Y. Sarin, Hong Zheng, Yashaar Chaichian, et al.
JCI Insight (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 5
Kavita Y. Sarin, Hong Zheng, Yashaar Chaichian, et al.
JCI Insight (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 5
Safety Profile of SARS-CoV-2 Vaccination in Patients with Lupus Nephritis: A Retrospective Study
Dimitra Petrou, Smaragdi Marinaki, Pelagia Kriki, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 406-406
Open Access
Dimitra Petrou, Smaragdi Marinaki, Pelagia Kriki, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 406-406
Open Access
Immunologic Response and Effects of COVID-19 Vaccines in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Ki Hyun Lee, Hyunsue Do, Jun Yong Choi, et al.
Yonsei Medical Journal (2025) Vol. 66
Open Access
Ki Hyun Lee, Hyunsue Do, Jun Yong Choi, et al.
Yonsei Medical Journal (2025) Vol. 66
Open Access
Severe Respiratory Infections in Rheumatoid Arthritis Patients: An Observational Study of 528 Patients from a Single University Hospital
L Domínguez-Casas, Iván Ferraz‐Amaro, Santos Castañeda, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1174-1174
Open Access
L Domínguez-Casas, Iván Ferraz‐Amaro, Santos Castañeda, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1174-1174
Open Access
Community-engaged curriculum development using racial justice and biomedical lenses to address COVID-19 vaccine hesitancy in black individuals with rheumatologic conditions
Eseosa Olive Osaghae, Greta Sirek, Tonya Roberson, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Eseosa Olive Osaghae, Greta Sirek, Tonya Roberson, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
Cinzia Rotondo, Francesco Paolo Cantatore, Marco Fornaro, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 730-730
Open Access | Times Cited: 35
Cinzia Rotondo, Francesco Paolo Cantatore, Marco Fornaro, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 730-730
Open Access | Times Cited: 35
Novel insights into the management of rheumatoid arthritis: one year in review 2023
Carlo Garaffoni, Antonella Adinolfi, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology (2023)
Open Access | Times Cited: 12
Carlo Garaffoni, Antonella Adinolfi, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology (2023)
Open Access | Times Cited: 12
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis
Pedro Martínez‐Fleta, Esther F. Vicente‐Rabaneda, Ana Triguero‐Martínez, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Pedro Martínez‐Fleta, Esther F. Vicente‐Rabaneda, Ana Triguero‐Martínez, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus
Nuntawan Piyaphanee, Sirirat Charuvanij, Sutheera Thepveera, et al.
Lupus (2024) Vol. 33, Iss. 5, pp. 450-461
Closed Access | Times Cited: 4
Nuntawan Piyaphanee, Sirirat Charuvanij, Sutheera Thepveera, et al.
Lupus (2024) Vol. 33, Iss. 5, pp. 450-461
Closed Access | Times Cited: 4
Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 4
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 4
Systemic Lupus Erythematosus and COVID-19
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 11
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 11
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Emily E. Holladay, Amy S. Mudano, Fenglong Xie, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 111-119
Closed Access | Times Cited: 8
Association of COVID‐19 Vaccinations With Flares of Systemic Rheumatic Disease: A Case‐Crossover Study
Genna Braverman, Medha Barbhaiya, Minerva Nong, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 5, pp. 733-742
Open Access | Times Cited: 2
Genna Braverman, Medha Barbhaiya, Minerva Nong, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 5, pp. 733-742
Open Access | Times Cited: 2
Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis
Zhaoxu Tian, Yonghua Chen, Yingxin Yao, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access | Times Cited: 2
Zhaoxu Tian, Yonghua Chen, Yingxin Yao, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access | Times Cited: 2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
Anna M. Zhang, Ahmed Elmoursi, Daniel DiGiacomo, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100234-100234
Open Access | Times Cited: 2
Anna M. Zhang, Ahmed Elmoursi, Daniel DiGiacomo, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100234-100234
Open Access | Times Cited: 2
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, et al.
Rheumatology International (2024) Vol. 44, Iss. 5, pp. 805-817
Closed Access | Times Cited: 2
C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, et al.
Rheumatology International (2024) Vol. 44, Iss. 5, pp. 805-817
Closed Access | Times Cited: 2
Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis
Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 12, pp. 3707-3714
Open Access | Times Cited: 12
Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 12, pp. 3707-3714
Open Access | Times Cited: 12
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases
Axel Finckh, Adrian Ciurea, Catherine Raptis, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S13-S23
Open Access | Times Cited: 6
Axel Finckh, Adrian Ciurea, Catherine Raptis, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S13-S23
Open Access | Times Cited: 6
